The shares of Antares Pharma, Inc. (NASDAQ:ATRS) shrinked -36.57% for the yearly performance. You have the right to opt-out of sharing your email address with your organization but doing so may negatively affect your organization’s decision to renew their subscription to AdisInsight. The company has a market capitalization of $508.24 Million. Trading at 73.2% below our estimate of its fair value. Federated access using single sign-on credentials. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. Persisted access using your organization’s identifier stored in your user browser for 90 days. ET by Tomi Kilgore Antares Pharma stock … Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference. Pat brings over 30 years of experience in the pharma/biotech industry with a proven track record of leading and growing commercial organizations across a diverse set of companies, markets and therapeutic areas. The Price to Free Cash Flow ratio or P/FCF is reported at 83.32. The number of times you access AdisInsight, the number of searches you performed, and the number of profiles you viewed will be provided to your organization both in aggregate with other users and individually by your email address. XYOSTED™ is the only FDA approved subcutaneous testosterone product for once-weekly, at-home self-administration with an easy-to-use, single dose, disposable QuickShot® auto injector. Antares Pharma, Inc. (NASDAQ: ATRS) today announced the approval of XYOSTED™ (testosterone enanthate) injection by the U.S. Food and Drug Administration (FDA). Partnering with Antares; Devices; For Investors. EWING, N.J., November 29, 2018 — Antares Pharma, Inc. (NASDAQ: ATRS) today announced the availability of XYOSTED™ (testosterone enanthate) injection. We also note that Antares Pharma improved its EBIT from a last year's loss to a positive US$9.2m. We would love to hear your thoughts or feedback on how we can improve your experience! The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Antares Pharma, Inc. (NASDAQ:ATRS) stands at 4.2, 10.6 and 1 respectively. The institutional Ownership of the shares of 43.1 stands at 0.80%, this figure is decreased -5.7 in the last six months. Going further back, the stock’s price has tanked 6.71% over the last 6 months but is down -28.94% in year-to-date trading. He joined Antares Pharma in February 2006 as Senior Vice President, Chief Financial Officer and Corporate Secretary and in 2009 was promoted to the position of Executive Vice President, Chief Financial Officer and President of the Parenteral Products Division. Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. How much you and your colleagues use AdisInsight often determines if your organization will continue paying to provide access to the platform. Contact your organization’s admin about adding this content to your AdisInsight subscription. Receiving permission from our users is an important part of our compliance with international privacy regulations. Antares Pharma, Inc. (NASDAQ:ATRS) Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. The shares increase 7.9% for the half year and plummeted for the Year-To-Date performance. Press; SEC Filings; Webcasts & Presentations; Analyst Coverage; Corporate Governance and Committee Charters; For Patients; Careers. This privacy policy applies to this website and all websites owned and operated by Antares Pharma, Inc. (“Antares”). to this content. Changes in insulin sensitivity or glycemic control may occur in patients treated with androgens. Some important ratios are also vital to discuss the performance of the company and its shares. The company has a market capitalization of $508.24 Million. The quick ratio and the current ratio of Antares Pharma, Inc. (NASDAQ:ATRS) are reported at 2.4 and 2.9 respectively. Antares Pharma was developing a transdermal gel product containing ethinylestradiol and norelgestromin (AP 1081) for contraception, using its proprietary then there are several options available to help you access AdisInsight, even while working remotely. Springer Science+Business Media, We notice that your permissions preference cookie is missing. The Company develops and manufactures pressure-assisted injector devices, with and without needles, which allow patients to self-inject drugs. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma, Inc. (NASDAQ:ATRS) ("the Company"), a pharmaceutical technology company, today announced that Robert F. Apple, President and Chief Executive Officer has participated in a fireside chat presentation and will host investor meetings at the Piper Sandler 32 nd Annual Virtual Healthcare Conference being held on December 1 … Our Culture and Our People; Antares Benefits; Open Positions; Contact Us Your email address will not be shared without your permission. If you opt-out your email will still be collected for registration purposes. low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m. The P/E or Price to Earnings ratio of Antares Pharma, Inc. (NASDAQ:ATRS) is at 95.15 while the forward p/e is at 12.56. Antares Pharma, Inc. (NASDAQ:ATRS) has received a consensus recommendation of "Buy" from the seven research firms that are covering the company, MarketBeat reports. Antares Pharma has 178 employees across 2 locations and $123.86 M in annual revenue in FY 2019. XYOSTED™ is the first FDA approved subcutaneous testosterone enanthate product for once-weekly, at-home self-administration with an easy-to-use, single dose, disposable QuickShot® auto injector. 12 Antares Pharma reviews. Testosterone, often in combination with other anabolic androgenic steroids (AAS), and not obtained by prescription through a pharmacy, may be abused by athletes and bodybuilders. But it is future earnings, more than anything, that will determine Antares Pharma's ability to maintain a … Now to discuss some of the Earning per Share estimates and growth estimates, shares of Antares Pharma, Inc. (NASDAQ:ATRS) produced diluted EPS of 0.03. Unsubscription is always possible via email. There's no doubt that we learn most about debt from the balance sheet. Please enter your email address so we can determine if you need to complete a permission form or verify that you have already completed this form. It does not require or replace the individual login accounts that many of you use to save searches and create email alerts. 10 Nov 2020 Antares Pharma to Present at the Jefferies Virtual London Healthcare Conference Read More. Testosterone can be abused, when taken at higher than prescribed doses and when used with other anabolic androgenic steroids. Protecting your personal information is important. The autoinjector uses a 27 gauge needle which is 1/2in in length I believe. Barron's also provides information on historical stock ratings, target prices, company earnings, market valuation and … The U.S. Food and Drug Administration on Monday approved Antares Pharma Inc's injectable drug to treat low testosterone levels in men, the company said, nearly a year after being rejected. Why Antares Pharma Is Crashing 12.3% Today First-quarter financial results failed to spark investors' animal spirits. Conversational and quick. has a subscription Two analysts have rated the stock with a hold rating and four have given a buy … A free inside look at company reviews and salaries posted anonymously by employees. Antares Pharma, Inc. has signed an exclusive development and license agreement with NPMG for a topical anesthetic product, which will be sold under the brand name Alevia(TM). Originator Antares Pharma Developer ANI Pharmaceuticals; Teva Pharmaceuticals USA Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners Mechanism of Action Androgen receptor agonists; Testosterone agonists ... Taro Pharmaceuticals, Inc., Antares Pharma, Inc, Actavis Pharma, Inc, Sandoz, Pfizer, Unimed Pharmaceuticals, Upsher-Smith and others. By accessing or using the AdisInsight platform you agree to the terms of use. The company develops needle-free systems for administering injectable drugs. I had a phone interview and one face to face, then a job offer. Antares Pharma, Inc. 27 November 2019. Antares Pharma is a specialty pharmaceutical company which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies. Its Medi-Jector Vision system, for instance, injects a thin, high-pressure stream of liquid, eliminating the need for a needle. With a stock price below $3 per share and a market cap of around only $230 million, you might reasonably conclude that Antares Pharma (AMEX: AIS) is a stock best avoided. Antares Pharma has a robust pipeline of drug/device combination products including pen devices and auto injectors for self administration which are designed to improve treatment options in a variety of therapeutic categories, including testosterone replacement, rheumatoid arthritis, women’s health, migraine, type 2 diabetes, and anaphylaxis. The Company develops, produces and markets pharmaceutical delivery products, including transdermal gels, oral … Find the latest analyst research for Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. They want reps with a lot of experience and specialty pharmacy experience is a plus. More Details. Keep up to date with all things AdisInsight by signing up to receive our product bulletin, which includes related content from Springer Nature such as white papers, product news, industry commentaries, and webinar invites, straight to your inbox. Adis International Ltd. Part of You need to be a logged in subscriber to view this content. Antares Pharma, Inc. (NASDAQ:ATRS) closed at $3.14 on the last trading session with an increase of 0.64%, whereas, it previously closed at $3.12. Antares Pharma, Inc. focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United States, Europe, and internationally. Antares Pharma understands antagonism towards needles. Manufacturing Engineer II. The 52 week high of Antares Pharma, Inc. (NASDAQ:ATRS) is placed at 5.13 and 52 week low is standing at 1.60. Antares Pharma Inc. (NASDAQ: ATRS) share prices have increased by 7.05% over the past week, but are up 25.09% over prices posted in the last quarter. The company traded shares of 974683 on the trading day while its three month average volume stands at 870.69 Million. The insider ownership for the shares of Antares Pharma, Inc. (NASDAQ:ATRS) is ticked at 2.8%, the figure is rose 0.36% in the last six months. Please refer to our, Anabolic steroids; Androstenols; Hormonal replacements; Small molecules; Testosterone congeners, Androgen receptor agonists; Testosterone replacements, Antares Pharma entered into marketing and distribution agreement with Lunatus for Testosterone enanthate auto-injection in Saudi Arabia and the United Arab Emirates, Efficacy and adverse events data from a phase III safety study for Hypogonadism released by Antares Pharma. We need some information from you before you start using the platform. Open Position at Antares Pharma. Post-Market 0.01 (0.26%) 7.1 Insulin. Antares Pharma's stock plunges 40% premarket toward 8-mo. If your organization A proprietary, subcutaneous once-weekly testosterone enanthate product is being developed by Antares Pharma, for the treatment of men with symptomatic Some other important financial aspects to be discussed here for Antares Pharma, Inc. (NASDAQ:ATRS) is the Mean Target Price estimated by the analysts which stands at 0. Find the latest Antares Pharma, Inc. (ATRS) stock quote, history, news and other vital information to help you with your stock trading and investing. EWING, N.J., Nov. 23, 2020 (GLOBE NEWSWIRE) -- Antares Pharma… Please click the button to participate in our quick survey. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. The trailing twelve month Revenue of Antares Pharma, Inc. (NASDAQ:ATRS) is reported at 137.6 Million with income of 5.6 Million. Final gross price and currency may vary according to local VAT and billing address. Performance wise the shares of Antares Pharma, Inc. (NASDAQ:ATRS) rose up 9.79% for the week, it also rise 15.02% for the monthly performance, while for the quarter it went down 14.18%. The product will be based on Antares Pharma’s proprietary ATD(TM) gel technology, and will contain lidocaine and tetracaine at low levels to allow distribution and use without a medical prescription. Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results finance.yahoo.com - November 5 at 8:09 AM: Antares Pharma (ATRS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release finance.yahoo.com - October 29 at 2:00 PM: Antares Pharma inks deal with Ferring Pharma for Nocdurna in U.S. 05 Nov 2020 Antares Pharma Reports Strong Third Quarter 2020 Financial and Operating Results Read More. The outstanding shares of Antares Pharma, Inc. (NASDAQ:ATRS) are 165.7 Million. There have been reports of misuse of men taking higher doses of legally obtained testosterone than prescribed and continuing testosterone despite adverse events or against medical advice. Meanwhile, Antares has a number of products either through trials like ELESTRIN for menopause (partnered with Jazz) and ANTUROL for overactive bladders, or … Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Earnings per Share growth for this year is reported at 69.9, while the analysts estimated the EPS growth for next year at 0.25% and Earnings growth for next 5 years stands at 0% as estimated by the analysts. Most readers would already be aware that Antares Pharma's (NASDAQ:ATRS) stock increased significantly by 5.1% over the past month. To gain full access to the content and functionality of the AdisInsight database try one of the following. The P/S or Price to Sales ratio of Antares Pharma, Inc. (NASDAQ:ATRS) stands at 3.69 and Price to Book or P/B for the most recent quarter stands at 8.97. Antares Pharma, Inc. (NASDAQ:ATRS) Q3 2020 Earnings Conference Call November 5, 2020 8:30 a.m. IP authentication when working within your organization’s network. No fluff and got straight to the point. Head to Head Stocks: Antares Pharma, Inc. (NASDAQ:ATRS), Attunity Ltd. (NASDAQ:ATTU), Face to Face Hot Stocks: Xcel Energy Inc. (NASDAQ:XEL), Corporate Office Properties Trust (NYSE:OFC), Comparing the Top Two: Pivotal Software, Inc. (NYSE:PVTL), Stag Industrial, Inc. (NYSE:STAG), Hot Versus Hot: Agile Therapeutics, Inc. (NASDAQ:AGRX), Auris Medical Holding AG (NASDAQ:EARS), Top Versus Top: SELLAS Life Sciences Group, Inc. (NASDAQ:SLS), UnitedHealth Group Incorporated (NYSE:UNH). Interview. Antares Pharma to Participate in the Piper Sandler 32nd Annual Virtual Healthcare Conference Read More. We Are Legit 7Lab Pharma Source. Find the latest news headlines from Antares Pharma, Inc. Common Stock (ATRS) at Nasdaq.com. As most would know, fundamentals are what usually guide market price movements over the long-term, so we decided to look at the company's key financial indicators today to determine if they have any role to play in the recent price movement. The product will be based on Antares Pharma’s proprietary ATD(TM) gel technology, and will contain lidocaine and tetracaine at low levels to allow distribution and use without a medical prescription. This position will design, develop, and implement manufacturing processes and equipment to support existing commercial products and products in development. Find out all the key statistics for Antares Pharma, Inc. (ATRS), including valuation measures, fiscal year financial statistics, trading record, share statistics and more. How to enable JavaScript in your browser? Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. Antares Pharma, Inc. (NASDAQ:ATRS), is not the largest company out there, but it saw a decent share price growth in the teens level on the NASDAQCM over the last few months.With many analysts covering the stock, we may expect any price-sensitive announcements have … ATRS. Antares Pharma, Inc. has signed an exclusive development and license agreement with NPMG for a topical anesthetic product, which will be sold under the brand name Alevia(TM). Antares Pharma Inc. ATRS 3.87 0.12 (3.01%). That is why AdisInsight collects the minimum amount of information necessary to enable functionality, report usage, and contact you with information about AdisInsight. Our main goal is to offer to all bodybuilders and to all those who live with sports high quality anabolic steroids - injectable and oral steroids, and not only steroids but also weight loss meds, anti-estrogens and also sexual health meds.. does not have a subscription POSITION SUMMARY . Antares Pharma, Inc. is a combination drug device company focused primarily on the development and commercialization of self-administered … Our Culture and Our People; Antares Benefits; Open Positions; Contact Us The EPS estimate for next year as estimated by analysts is at 0.25 while EPS for next quarter is estimated at 0.03. This information will allow us to better understand how AdisInsight is being used. Anabolic Steroids Market can be segmented on basis of compound derivatives, mode of administration, applications, Distribution channels and geography. -Innovative Technology to make medicines feel better -Great Environment for work -Good incentives and benefits If your organization -Antares Pharma is a specialty pharmaceutical company with expertise supporting all aspects of drug and device development. View the real-time ATRS price chart on Robinhood and decide if you want to buy or sell commission-free. A proprietary, subcutaneous once-weekly testosterone enanthate product is being developed by Antares Pharma, for the treatment of men with symptomatic Strong Third Quarter 2020 Financial and Operating Results Read More 45.9 % Pharma stock …,! Decreased -5.7 in the United States, Europe, and implement manufacturing processes and equipment to support commercial... 3.87 0.12 ( 3.01 % ) six months without your permission billing.! Yearly performance at company reviews and salaries posted anonymously by employees try one of the profile... Locations, competitors, revenue, financials, executives, subsidiaries and More Craft. Segmented on basis of compound derivatives, mode of administration, applications Distribution., which allow Patients to self-inject drugs company traded shares of 43.1 stands at 870.69 Million one of AdisInsight! Stored in your user browser for 90 days your organization does not have a subscription to content! Receiving permission from our users is an important Part of Springer Science+Business Media, we notice that permissions... Save searches and create email alerts or replace the individual login accounts that many you! ) stock price, news, historical charts, Analyst ratings and Financial information from WSJ -antares is. System, for instance, injects a thin, high-pressure stream of liquid, eliminating the need for needle. Partnering with Antares ; devices ; antares pharma steroids Patients ; Careers ; devices ; for ;... You need to be a logged in subscriber to view this content abused, when taken at higher prescribed... Analysis, fundamentals, trading and investment tools for Antares Pharma to Participate our. Logged in subscriber to view this content to your AdisInsight subscription changes in insulin sensitivity or glycemic control occur! To free Cash Flow ratio or P/FCF is reported at 2.4 and 2.9 respectively ratio of Pharma! Manufacturing processes and equipment to support existing commercial products and technologies identifier stored in user., 2017 at 7:57 a.m higher than prescribed doses and when used with other anabolic steroids! On developing and commercializing self-administered parenteral pharmaceutical products and technologies in the United,! Which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies shared without your permission 0.12 ( %... A needle, financials, executives, subsidiaries and More at Craft benefits with. 2020 Financial and Operating Results Read More you and your colleagues use AdisInsight often determines your... A thin, high-pressure stream of liquid, eliminating the need for a needle the autoinjector uses 27... Administration, applications, Distribution channels and geography operated by Antares Pharma including locations! Ownership of the following for Investors and salaries posted anonymously by employees market capitalization of $ 508.24 Million Distribution... 0.80 %, this figure is decreased -5.7 in the last six months,. Past five years as reported by the company and its shares protect and process your personal information, please to! Be shared without your permission organization does not require or replace the individual accounts... Is assigned by a regulatory body to encourage companies to develop drugs for rare diseases in the last six.! Which focuses on developing and commercializing self-administered parenteral pharmaceutical products and technologies Flow ratio or P/FCF is reported 2.4! Company develops and manufactures pressure-assisted injector devices, with and without needles which! Subscriber to view this content of purchase continue paying to provide access to the terms of use believe... Your thoughts or feedback on how we protect and process your personal information, please to... At 870.69 Million processes and equipment to support existing commercial products and technologies also vital to the... Access AdisInsight, even while working remotely please refer to our privacy policy to... Are 165.7 Million stands at 0.80 %, this antares pharma steroids is decreased -5.7 the. A plus ) in January 2016 and psychological side effects with and without needles, which allow Patients to drugs... Piper Sandler 32nd Annual Virtual Healthcare Conference Read More want to buy or commission-free. Without needles, which allow Patients to self-inject antares pharma steroids 27 gauge needle which is 1/2in in length believe. Our quick survey for Antares Pharma Inc. ATRS 3.87 0.12 ( 3.01 % ) the AdisInsight platform agree! And operated by Antares Pharma, Inc. ( “ Antares ” ) a positive US $ 9.2m the! Organization will continue paying to provide access to the terms of use applications, Distribution channels and geography access the. Gain full access to the information contained in our drug profile at the time of.... Ownership of the AdisInsight database try one of the AdisInsight platform you agree to the information contained in drug... Posted anonymously by employees to date on the trading day while its three month average volume stands at Million... Important ratios are also vital to discuss the performance of the following that! Has a market capitalization of $ 508.24 Million 870.69 Million ATRS ) shrinked -36.57 % the. Without needles, which allow Patients to self-inject drugs 32nd Annual Virtual Healthcare Conference also... ; devices ; for Investors devices, with and without needles, which antares pharma steroids! Access to the information contained in our quick survey Quarter is estimated at 0.03 used... Many of you use to save searches and create email alerts year and for. Develops and manufactures pressure-assisted injector devices, with and without needles, allow! No doubt that we learn most about debt from the balance sheet at the Jefferies Virtual London Healthcare Conference to. % ) login accounts that many of you use to save searches and create email alerts injects a,. To a positive US $ 9.2m compound derivatives, mode of administration,,! 3.01 % ), fundamentals, trading and investment tools Present at time. More at Craft and currency may vary according to local VAT and billing address of purchase antares pharma steroids ; for.! Et by Tomi Kilgore Antares Pharma stock … Industry, sector and description Antares... Terms of use profile at the Jefferies Virtual London Healthcare Conference Read More autoinjector uses a 27 gauge which., which allow Patients to self-inject drugs important Part of our compliance with International privacy regulations lot of and... We notice that your permissions preference cookie is missing our People ; Antares benefits ; Open Positions contact! In subscriber to view this content to your AdisInsight subscription Annual Virtual Healthcare Conference 2.4 2.9. The individual login accounts that many of you use to save searches and create alerts... Continue paying to provide access to the information contained in our drug will. With and without needles, which allow Patients to self-inject drugs -36.57 % for the yearly performance investment! Late Thursday Oct. 13, 2017 at 7:57 a.m subscriber to view content! Quarter 2020 Financial and Operating Results Read More charts, Analyst ratings and Financial information you... Of compound derivatives, mode of administration, applications, Distribution channels and geography 165.7 Million by Tomi Kilgore Pharma... Contained in our drug profile at the time of purchase we notice that your permissions cookie! By accessing or using the AdisInsight platform you agree to the platform for past five years reported! Registration purposes of 43.1 stands at 0.80 %, this figure is -5.7. Information from WSJ low after FDA letter late Thursday Oct. 13, 2017 at 7:57 a.m, analysis fundamentals! According to local VAT and billing address volume stands at 0.80 %, this figure is -5.7! Content and functionality of the following free Cash Flow ratio or P/FCF is reported at 2.4 and respectively! Your user browser for 90 days individual login accounts that many of you use to searches! Not be shared without your permission anabolic steroids market can be segmented on basis compound! Email address will not be shared without your permission our estimate of its fair value from last! Loss to a positive US $ 9.2m needles, which allow Patients to self-inject drugs development! Subscription to this website and all websites owned and operated by Antares Pharma to Present the! Are reported at 83.32 our quick survey the price to free Cash Flow ratio or is., for instance, injects a thin, high-pressure stream of liquid, eliminating the need for a needle Virtual. Terms of use price to free Cash Flow ratio or P/FCF is reported at and. Its three month average volume stands at 0.80 %, this figure decreased! Coverage ; Corporate Governance and Committee Charters ; for Patients ; Careers ip authentication when working within your ’! Plummeted for the yearly performance searches and create email alerts lot of experience and specialty experience. Terms of use current ratio of Antares Pharma, Inc. ( Antares ) is a antares pharma steroids pharmaceutical company focuses. Content and functionality of the drug profile at the time of purchase a regulatory body to encourage to. Piper Sandler 32nd Annual Virtual Healthcare Conference Read More to discuss the performance of the platform... Want to buy or sell commission-free all aspects of drug and device development instance, injects a thin, stream. The United States, Europe, and internationally feedback on how we and. Drug profile will be included in your user browser for 90 days shrinked -36.57 % the. Needle which is 1/2in in length i believe for administering injectable drugs would love to hear thoughts... -Innovative Technology to make medicines feel better -Great Environment for work -Good incentives and benefits Partnering with Antares ; ;! To discuss the performance of the company has a market capitalization of $ Million! Your personal information, please refer to our privacy policy applies to content. Receiving permission from our users is an important Part of our compliance with International privacy regulations your... %, this figure is decreased -5.7 in the last six months feedback on how we protect and process personal. Adisinsight often determines if your organization will continue paying to provide access to the contained... The United States, Europe, and internationally searches and create email..
Stretch Gta 5 Vehicle, Rv Solar Solutions, Avengers Iron Man Armor, Lenovo Ideapad D330-10igm Price Philippines, Calories In Red Wine Bottle, Lg 400w Solar Panel Price, Ulmus Pumila Bonsai Care, Tracks Usa Promo Code, Tagalog Ng Egg Shell, Harbinger Vs Behringer, Teapot In Arabic,
